Publications dans lesquelles il/elle collabore avec Marina Machado (25)

2024

  1. Candida spp.: the burden of a microorganism in a microbiology department

    Microbiology Spectrum, Vol. 12, Núm. 8

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  3. Nosocomial Infections in Adult Patients Supported by Extracorporeal Membrane Oxygenation in a Cardiac Intensive Care Unit

    Microorganisms, Vol. 11, Núm. 4

2022

  1. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  2. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283

  3. Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest

    Microbiology spectrum, Vol. 10, Núm. 2, pp. e0262621

  4. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  5. Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission

    Journal of Fungi, Vol. 8, Núm. 3

  6. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  7. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  2. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  3. Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain

    Expert Review of Clinical Pharmacology, Vol. 14, Núm. 2, pp. 249-260

  4. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  5. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

  6. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  7. Utility of 1,3 β-d-glucan assay for guidance in antifungal stewardship programs for oncologic patients and solid organ transplant recipients

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-12

2020

  1. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults with Candidemia: A 5-year Experience in a Tertiary Hospital

    Clinical Infectious Diseases, Vol. 70, Núm. 9, pp. 1925-1932

  2. Efficacy of a “Checklist” Intervention Bundle on the Clinical Outcome of Patients with Candida Bloodstream Infections: A Quasi-Experimental Pre-Post Study

    Infectious Diseases and Therapy, Vol. 9, Núm. 1, pp. 119-135